Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Cancer Drug Combination Pricing: Genentech Offers Model For Tecentriq, Avastin

Jan 23 2019

• By Cathy Kelly

vialandmultiplesyringes_1200x675

Related Content

Genentech, Amgen Face Big Impact From Part B International Pricing Index

Oct 31 2018

Can Medicare International Price Index Model Avoid Part B Demo Pitfalls?

Oct 28 2018

Part B Payment Model Indexing Commercial Discounts Proposed By Genentech

Oct 24 2018

Roche's Tecentriq Becomes Second In PD-1/L1 Family To Gain First-Line Lung Cancer Approval

Dec 07 2018

Related Companies

Genentech, Inc.

Additional Topics

United States Pricing Debate Policy Reimbursement Government Payers Cancer BioPharmaceutical

More from Pricing Debate

More from Market Access

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window